U.S. trade negotiator discusses COVID-19 IP waiver with Moderna CEO
U.S. Trade Representative Katherine Tai on Wednesday met virtually with the top executive of drugmaker Moderna (MRNA.O) to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic, Tai’s office said.